基金Supported by Grants of the Deutsche Forschungsgemeinschaft(to zur Wiesch JS),No.DFG Grant LU B62/2-1 and No.SFB841 A6the Deutsches Zentrum für Infektionsforschung(to zur Wiesch JS)
文摘AIM: To evaluate the safety and efficacy of pegylated interferon alfa-2a and ribavirin therapy in elderly patients with chronic hepatitis C infection.
